Cargando…

Application of the adenosine triphosphate sensitivity assay in infantile vascular anomalies

BACKGROUND: The term vascular anomalies include various vascular tumors and vascular malformations, among them infantile hemangiomas and capillary malformations are the most well-known associated diseases in early ages. Multiple drugs have been introduced for intervention, but susceptibility test in...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Li, Yang, Bin, Wei, Li, Zhang, Bin, Han, Xiao-feng, Xu, Zi-gang, Ma, Lin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7029611/
https://www.ncbi.nlm.nih.gov/pubmed/32075603
http://dx.doi.org/10.1186/s12887-020-1974-9
_version_ 1783499206868074496
author Li, Li
Yang, Bin
Wei, Li
Zhang, Bin
Han, Xiao-feng
Xu, Zi-gang
Ma, Lin
author_facet Li, Li
Yang, Bin
Wei, Li
Zhang, Bin
Han, Xiao-feng
Xu, Zi-gang
Ma, Lin
author_sort Li, Li
collection PubMed
description BACKGROUND: The term vascular anomalies include various vascular tumors and vascular malformations, among them infantile hemangiomas and capillary malformations are the most well-known associated diseases in early ages. Multiple drugs have been introduced for intervention, but susceptibility test in vitro were scarcely reported. OBJECTIVE: To evaluate the inhibition effect of different drugs by adenosine triphosphate sensitivity assay in vitro before the treatment of infantile hemangiomas and capillary malformations. METHODS: Specimens were selected from 5 cases of infantile hemangiomas and 11 cases of capillary malformations. Propranolol, rapamycin, sildenafil and itraconazole were tested for their growth inhibition effect by using the adenosine triphosphate sensitivity assay. RESULTS: Propranolol demonstrated inhibitory effects on infantile hemangiomas cells. Rapamycin and itraconazole both showed inhibitory effects on infantile hemangiomas cells and capillary malformations cells. Sildenafil has no growth inhibitory effect on infantile hemangiomas cells or capillary malformations cells. CONCLUSION: Adenosine triphosphate sensitivity assay is a sensitive and useful testing method before the management of vascular anomalies, and individualized medication suggestions for the choice of therapeutic drugs were offered based on the testing result and together with a comprehensive evaluation of each infant.
format Online
Article
Text
id pubmed-7029611
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-70296112020-02-25 Application of the adenosine triphosphate sensitivity assay in infantile vascular anomalies Li, Li Yang, Bin Wei, Li Zhang, Bin Han, Xiao-feng Xu, Zi-gang Ma, Lin BMC Pediatr Research Article BACKGROUND: The term vascular anomalies include various vascular tumors and vascular malformations, among them infantile hemangiomas and capillary malformations are the most well-known associated diseases in early ages. Multiple drugs have been introduced for intervention, but susceptibility test in vitro were scarcely reported. OBJECTIVE: To evaluate the inhibition effect of different drugs by adenosine triphosphate sensitivity assay in vitro before the treatment of infantile hemangiomas and capillary malformations. METHODS: Specimens were selected from 5 cases of infantile hemangiomas and 11 cases of capillary malformations. Propranolol, rapamycin, sildenafil and itraconazole were tested for their growth inhibition effect by using the adenosine triphosphate sensitivity assay. RESULTS: Propranolol demonstrated inhibitory effects on infantile hemangiomas cells. Rapamycin and itraconazole both showed inhibitory effects on infantile hemangiomas cells and capillary malformations cells. Sildenafil has no growth inhibitory effect on infantile hemangiomas cells or capillary malformations cells. CONCLUSION: Adenosine triphosphate sensitivity assay is a sensitive and useful testing method before the management of vascular anomalies, and individualized medication suggestions for the choice of therapeutic drugs were offered based on the testing result and together with a comprehensive evaluation of each infant. BioMed Central 2020-02-19 /pmc/articles/PMC7029611/ /pubmed/32075603 http://dx.doi.org/10.1186/s12887-020-1974-9 Text en © The Author(s). 2020 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Li, Li
Yang, Bin
Wei, Li
Zhang, Bin
Han, Xiao-feng
Xu, Zi-gang
Ma, Lin
Application of the adenosine triphosphate sensitivity assay in infantile vascular anomalies
title Application of the adenosine triphosphate sensitivity assay in infantile vascular anomalies
title_full Application of the adenosine triphosphate sensitivity assay in infantile vascular anomalies
title_fullStr Application of the adenosine triphosphate sensitivity assay in infantile vascular anomalies
title_full_unstemmed Application of the adenosine triphosphate sensitivity assay in infantile vascular anomalies
title_short Application of the adenosine triphosphate sensitivity assay in infantile vascular anomalies
title_sort application of the adenosine triphosphate sensitivity assay in infantile vascular anomalies
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7029611/
https://www.ncbi.nlm.nih.gov/pubmed/32075603
http://dx.doi.org/10.1186/s12887-020-1974-9
work_keys_str_mv AT lili applicationoftheadenosinetriphosphatesensitivityassayininfantilevascularanomalies
AT yangbin applicationoftheadenosinetriphosphatesensitivityassayininfantilevascularanomalies
AT weili applicationoftheadenosinetriphosphatesensitivityassayininfantilevascularanomalies
AT zhangbin applicationoftheadenosinetriphosphatesensitivityassayininfantilevascularanomalies
AT hanxiaofeng applicationoftheadenosinetriphosphatesensitivityassayininfantilevascularanomalies
AT xuzigang applicationoftheadenosinetriphosphatesensitivityassayininfantilevascularanomalies
AT malin applicationoftheadenosinetriphosphatesensitivityassayininfantilevascularanomalies